v3.26.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Revenues $ 7,806
Operating expenses:    
Research and development 38 7,166
General and administrative 5,131 7,785
Loss on MannKind Transaction 2,618
Total operating expenses 5,169 17,569
Loss from operations (5,169) (9,763)
Other income (expense):    
Interest income 144 467
Fair value adjustment of warrants 67 (67)
Other expense, net (204) (196)
Total other income (expense), net 7 204
Net loss $ (5,162) $ (9,559)
Net loss per share attributable to common stockholders - basic $ (1.41) $ (2.62)
Net loss per share attributable to common stockholders - diluted $ (1.41) $ (2.62)
Weighted average common shares outstanding - basic 3,652,285 3,652,285
Weighted average common shares outstanding - diluted 3,652,285 3,652,285